National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
   
 
Results: 1 -5 of 5         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II


Supportive care


Active


18 and over


Other


217/2005
NCT00525967


2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Supportive care


Active


18 and over


Other


ACETAPLAC
NCT00152854


3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Supportive care, Treatment


Active


18 to 70


Other


CDHA008
NCT00299039

First Published: 7/8/2008  

4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Supportive care, Treatment


Active


18 to 75


Other


IB-MEDOR
2007-16, IB-2007-16, INCA-RECF0498, EUDRACT-2007-002686-13, NCT00712712


5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Biomarker/Laboratory analysis, Treatment


Active


18 to 75


Pharmaceutical / Industry


CSTI571A2107
NCT00428909

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov